Alexion Pharmaceuticals, Inc. ALXN announced a CFO succession plan, as incumbent Paul Clancy has decided to step down, although he will serve as senior advisor through mid-2020. The company said Aradhana Sarin, currently serving as chief strategy and business officer, will succeed Clancy as CFO.